Clinical Trials · NCT02887625

Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

UnknownN/AExenatide (Unclear)
Phase
N/A
Recruitment status
Unknown
Sponsor
Dr. Muhammad Abdulghani
Enrollment
410
Start date
Feb 2015
Locations
1 site, Qatar
Primary endpoint
HbA1c
View Exenatide compound reference